191 related articles for article (PubMed ID: 14150758)
1. THE BASIS FOR IMMUNITY TO MOUSE TYPHOID. 3. CELL-BOUND ANTIBODY.
ROWLEY D; TURNER KJ; JENKIN CR
Aust J Exp Biol Med Sci; 1964 Apr; 42():237-48. PubMed ID: 14150758
[No Abstract] [Full Text] [Related]
2. THE BASIS FOR IMMUNITY TO MOUSE TYPHOID. 2. ANTIBODY FORMATION DURING THE CARRIER STATE.
TURNER KJ; JENKIN CR; ROWLEY D
Aust J Exp Biol Med Sci; 1964 Apr; 42():229-36. PubMed ID: 14150757
[No Abstract] [Full Text] [Related]
3. THE BASIS FOR IMMUNITY TO MOUSE TYPHOID. I. THE CARRIER STATE.
JENKIN CR; ROWLEY D; AUZINS I
Aust J Exp Biol Med Sci; 1964 Apr; 42():215-28. PubMed ID: 14150756
[No Abstract] [Full Text] [Related]
4. BASIS FOR IMMUNITY TO TYPHOID IN MICE AND THE QUESTION OF "CELLULAR IMMUNITY".
JENKIN CR; ROWLEY D
Bacteriol Rev; 1963 Dec; 27(4):391-404. PubMed ID: 14097348
[No Abstract] [Full Text] [Related]
5. Antigenic determinants of Salmonella for production of "clearance" factor in mouse typhoid.
Nakano M; Saito K; Toyasaki N
Jpn J Microbiol; 1970 Mar; 14(2):163-70. PubMed ID: 4910537
[No Abstract] [Full Text] [Related]
6. Problems of anti-typhoid immunity and protective vaccination against typhoid.
Karolcek J
Lek Pr; 1969; 7(1):3-153. PubMed ID: 4917329
[No Abstract] [Full Text] [Related]
7. DETECTION OF TYPHOID CARRIERS.
BOKKENHEUSER V
Am J Public Health Nations Health; 1964 Mar; 54(3):477-86. PubMed ID: 14128664
[No Abstract] [Full Text] [Related]
8. The behaviour of a mutant strain of Salmonella typhimurium in experimental mouse typhoid.
HOBSON D
J Hyg (Lond); 1957 Sep; 55(3):322-33. PubMed ID: 13475777
[No Abstract] [Full Text] [Related]
9. [CYTOLOGICAL STUDY OF THE PROCESS OF IMMUNOGENESIS FOLLOWING ADMINISTRATION OF THE VI-ANTIGEN OF TYPHOID BACTERIA. I].
POKROVSKAIA MP; KRASKINA NA; GUTOROVA NM; LEVENSON VI; ZHUKOV VG; ALLILUEV AP
Zh Mikrobiol Epidemiol Immunobiol; 1963 Aug; 40():9-14. PubMed ID: 14091809
[No Abstract] [Full Text] [Related]
10. [ON STUDIES ON TYPHOID BACILLI CARRIERS. II].
MUENNICH D; LAKATOS M
Z Gesamte Inn Med; 1963 Aug; 18():694-701. PubMed ID: 14085699
[No Abstract] [Full Text] [Related]
11. Suggested adoption of a non-motile variant of strain Ty 2 for vaccination against typhoid fever.
Anderson ES
Prog Immunobiol Stand; 1971; 5():373-7. PubMed ID: 4573944
[No Abstract] [Full Text] [Related]
12. [IMMUNITY AND ANTIBIOTICS. EFFECT OF CHLORAMPHENICOL AND STREPTOMYCIN ON THE PRODUCTION OF ANTIBODIES AGAINST SALMONELLA TYPHI IN RABBITS].
CANTONIDEANZALONE H; GRASIDE A
An Fac Med Univ Repub Montev Urug; 1964; 49():417-20. PubMed ID: 14290778
[No Abstract] [Full Text] [Related]
13. Specific and cross-reactive immune response to oral Salmonella Typhi Ty21a and parenteral Vi capsular polysaccharide typhoid vaccines administered concomitantly.
Pakkanen SH; Kantele JM; Savolainen LE; Rombo L; Kantele A
Vaccine; 2015 Jan; 33(3):451-8. PubMed ID: 25433216
[TBL] [Abstract][Full Text] [Related]
14. Prevention of development of carriers in typhoid and paratyphoid fever.
Kilesso VA; Bilibin AF; Tendetnik YY; Kornilova II; Antonova IV; Musabayev IK; Nevsky MV; Kusminova ML; Vasilyeva AV
J Hyg Epidemiol Microbiol Immunol; 1973; 17(1):95-103. PubMed ID: 4196796
[No Abstract] [Full Text] [Related]
15. [CHANGES IN ANTIBACTERIAL IMMUNITY TO TYPHOID UNDER THE INFLUENCE OF DYSENTERY INFECTION AND INFLUENZA].
PINEGIN BV
Zh Mikrobiol Epidemiol Immunobiol; 1963 Aug; 40():29-34. PubMed ID: 14091794
[No Abstract] [Full Text] [Related]
16. Study on the production of IgG, IgA- and IgM-antibodies to somatic antigens of Salmonella typhi in humans.
Chernokhvostova E; Luxemburg KI; Starshinova V; Andreeva N; German G
Clin Exp Immunol; 1969 Apr; 4(4):407-21. PubMed ID: 4182404
[TBL] [Abstract][Full Text] [Related]
17. [Treatment of patients with typhoid and paratyphoid fever by use of typhoid-paratyphoid B vaccines with the aim of prevention of carrier state formation].
Bilibin AF; Kornilova II; Antonova IV; Kilesso VA; Riadneva OE; Taratorina OM; Izmaĭlova NB; Khazanova LE
Klin Med (Mosk); 1965 Aug; 43(8):112-7. PubMed ID: 4957973
[No Abstract] [Full Text] [Related]
18. [EVALUATION OF VACCINES AND OF THE EFFECTIVENESS OF VACCINATIONS AGAINST TYPHOID FEVER. XI. EVALUATION OF THE IMMUNOGENIC CAPACITY OF K, N, P, S, T VACCINES BY AN ACTIVE TEST ON MICE INFECTED WITH S. TYPHI WITH ZYMOSAN].
KOSTRZEWSKI J; PLACHCINSKA J
Przegl Epidemiol; 1963; 17():71-80. PubMed ID: 14053747
[No Abstract] [Full Text] [Related]
19. [VIRULENCE OF LEVOMYCETIN-RESISTANT TYPHO-PARATYPHOID BACTERIA ISOLATED FROM TYPHOID PATIENTS AND CARRIERS FOLLOWING LEVOMYCETIN THERAPY].
GNETNEV AM
Antibiotiki; 1964 Aug; 9():750-3. PubMed ID: 14239569
[No Abstract] [Full Text] [Related]
20. [Studies on experimental typhoid. 8c) Intracellular inhibition of the growth of S. typhi murium, S. cholerae suis, and E. coli O-55 in mononuclear phagocytes from the abdominal cavity of mice super-immunized with live Salmonella enteritidis vaccine].
SATO I; TANAKA T; SAITO K; MITSUHASHI S
Nihon Saikingaku Zasshi; 1961 Oct; 16():877-86. PubMed ID: 14497411
[No Abstract] [Full Text] [Related]
[Next] [New Search]
